Bandaram Pharma Packtech Limited submitted a regulatory disclosure to BSE Limited in response to exchange surveillance communication reference L/SURV/ONL/PV/SJ/2026-2027/4027 dated July 6, 2026 regarding unusual movement in the company's share price.
The company explicitly stated that there are no events, information, or developments that have any bearing on the operation or performance of the company, including any price-sensitive information that could result in the increase of the company's share price. This confirmation is provided in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The disclosure affirms that no extraordinary events have taken place within the company that would cause the rise in share price. The company committed to promptly intimate the exchange should any such events arise in the future.
The communication was signed by Deepak Reddy Bandaram, Chairman & Managing Director (DIN: 07074102), and digitally executed on July 7, 2026 at 17:26:02 IST. The company's CIN is L93090KA1993PLC159827.
Financial Impact
No financial impact disclosed. The company explicitly stated no material events affecting operations or performance have occurred.